Neogen Corporation (NEOG) vs TransMedics Group, Inc. (TMDX)
A side-by-side comparison of Neogen Corporation and TransMedics Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NEOG
Neogen Corporation
$12.28HealthcareDelayed quote: Oct 6, 2026, 12:30 PM EDT
TMDX
TransMedics Group, Inc.
$80.98HealthcareDelayed quote: Oct 6, 2026, 12:30 PM EDT
Total return — NEOG vs TMDX
growth of $100 · dividends reinvested · last 7yNEOG -54.9% (-10.7%/yr)TMDX +271.2% (+20.6%/yr)TMDX compounded faster over this window
Log scale — wide-divergence pair
NEOG TMDX
NEOG vs TMDX: by the numbers
- •TMDX is the larger company ($2.80B vs $2.68B market cap).
- •TMDX is profitable (22.69% net margin) while NEOG runs a net loss (-0.91%).
- •TMDX grew revenue faster over the past five years (86.12% vs 13.19% CAGR).
Metrics side by side
Valuation
| Metric | NEOG | TMDX |
|---|---|---|
| P/E ratio | N/A | 20.98 |
| Forward P/E | 39.61 | 55.20 |
| P/S ratio | 3.08 | 4.19 |
| P/B ratio | 1.28 | 5.40 |
| EV / EBITDA | 32.78 | 27.06 |
| FCF yield | N/A | 2.82% |
Profitability
| Metric | NEOG | TMDX |
|---|---|---|
| Gross margin | 46.93% | 58.69% |
| Operating margin | -2.49% | 12.21% |
| Net margin | -0.91% | 22.69% |
| ROE | -0.38% | 29.28% |
| ROIC | -0.68% | 5.87% |
Growth (annualized)
| Metric | NEOG | TMDX |
|---|---|---|
| Revenue CAGR (5Y) | 13.19% | 86.12% |
| Total return CAGR (5Y) | -21.13% | 21.77% |
Frequently asked
- Which has grown faster, NEOG or TMDX?
- Over the past five years, TMDX grew revenue faster — NEOG at a 13.19% CAGR versus TMDX at 86.12%.
- Is NEOG or TMDX more profitable?
- TMDX runs the higher net margin — NEOG at -0.91% versus TMDX at 22.69%.
- How have NEOG and TMDX total returns compared?
- Over the past 5 years, NEOG delivered -21.13% and TMDX delivered 21.77% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
TransMedics P/E ratioNeogen ROETransMedics ROENeogen operating marginTransMedics operating marginNeogen revenue growthTransMedics revenue growthNeogen free cash flowTransMedics free cash flow
Neogen & TransMedics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.